血管风险通过脑淀粉样蛋白负荷预测载脂蛋白E ε4携带者的血浆淀粉样β 42/40
研究纳入UCD-ADRC队列96名和阿尔茨海默病神经影像学倡议104名非痴呆老年人,采用横断面设计分析血管风险评分、APOE ε4状态、脑淀粉样负荷(Florbetapir-PET)与血浆aβ42/40的关系。结果显示血管风险与血浆aβ42/40的间接关联仅见于APOE ε4携带者。
要点
- 血管风险评分由高血压、糖尿病、高脂血症、冠心病和脑血管病相加构成
- 脑淀粉样负荷与血浆aβ42/40的关联在两个队列中均存在
- 血管风险经脑淀粉样负荷与血浆aβ42/40的间接关联仅在APOE ε4携带者中一致观察到
核心结论
- 血管风险仅通过脑淀粉样负荷与血浆aβ42/40水平呈间接关联,且仅见于APOE ε4携带者。
- 作者认为,对具有痴呆遗传易感性的非痴呆老年人,可能受益于仔细监测血管危险因素。
研究设计与样本
- 采用横断面设计,样本来自UCD-ADRC研究(n=96)和阿尔茨海默病神经影像学倡议(n=104),后者作为验证队列。
- 采用线性回归并进行中介分析;血管风险评分为高血压、糖尿病、高脂血症、冠心病和脑血管病之和;脑淀粉样负荷用Florbetapir-PET定量;所有模型均纳入基线年龄作为协变量。
主要发现
- 血管风险显著预测阿尔茨海默病神经影像学倡议队列的脑淀粉样负荷,但在UCD-ADRC队列中未显著预测。
- 脑淀粉样负荷在两个队列中均与血浆aβ42/40相关。
- 在阿尔茨海默病神经影像学倡议队列中,血管风险升高经脑淀粉样负荷与血浆aβ42/40降低呈间接关联,但UCD-ADRC队列中未见该间接关联。
- 按APOE ε4分层后,该间接关系在两个队列中仅于APOE ε4携带者中一致观察到。
临床怎么用
- 作者认为,具有痴呆遗传易感性且认知下降加速风险的非痴呆老年人,可能受益于仔细监测与脑淀粉样负荷直接相关、与血浆aβ42/40间接相关的血管危险因素。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Understanding the neurobiological underpinnings between established multimodal dementia risk factors and noninvasive blood-based biomarkers may lead to greater precision and earlier identification of older adults at risk of accelerated decline and dementia. We examined whether key vascular and genetic risk impact the association between cerebral amyloid burden and plasma aβ (amyloid β) 42/40 in nondemented older adults. METHODS: We used nondemented older adults from the UCD-ADRC (University of California, Davis-Alzheimer's Disease Research Center) study (n=96) and Alzheimer's Disease Neuroimaging Initiative (n=104). Alzheimer's Disease Neuroimaging Initiative was examined as confirmatory study cohort. We followed a cross-sectional design and examined linear regression followed by mediation analyses. Vascular risk score was obtained as the sum of hypertension, diabetes, hyperlipidemia, coronary artery disease, and cerebrovascular disease. Apolipoprotein E (APOE) ε4+ risk was genotyped, and plasma aβ42 and aβ40 were assayed. Cerebral amyloid burden was quantified using Florbetapir-PET scans. Baseline age was included as a covariate in all models. RESULTS: Vascular risk significantly predicted cerebral amyloid burden in Alzheimer's Disease Neuroimaging Initiative but not in the UCD-ADRC cohort. Cerebral amyloid burden was associated with plasma aβ 42/40 in both cohorts. Higher vascular risk increased cerebral amyloid burden was indirectly associated with reduced plasma aβ 42/40 in Alzheimer's Disease Neuroimaging Initiative but not in UCD-ADRC cohort. However, when stratified by APOE ε4+ risk, we consistently observed this indirect relationship only in APOE ε4+ carriers across both cohorts. CONCLUSIONS: Vascular risk is indirectly associated with the level of plasma aβ 42/40 via cerebral amyloid burden only in APOE ε4+ carriers. Nondemented older adults with genetic vulnerability to dementia and accelerated decline may benefit from careful monitoring of vascular risk factors directly associated with cerebral amyloid burden and indirectly with plasma aβ 42/40.
引用
- Sapkota S, Erickson K, Fletcher E, et al. Vascular Risk Predicts Plasma Amyloid β 42/40 Through Cerebral Amyloid Burden in Apolipoprotein E ε4 Carriers. Stroke. 2023. PMID: 37021572. doi:10.1161/STROKEAHA.122.041854
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。